# Study of the Safety and Immunogenicity of H1N1 Vaccine

> **NCT01177202** · PHASE1 · COMPLETED · sponsor: **Fraunhofer, Center for Molecular Biotechnology** · enrollment: 80 (actual)

## Conditions studied

- H1N1 Flu

## Interventions

- **BIOLOGICAL:** HAC1 Vaccine

## Key facts

- **NCT ID:** NCT01177202
- **Lead sponsor:** Fraunhofer, Center for Molecular Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-05
- **Final completion:** 2012-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-07-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01177202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01177202, "Study of the Safety and Immunogenicity of H1N1 Vaccine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01177202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*